Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Diabetes: Time to Use the Technology We Already Have

Author(s): Elena Vakali*

Volume 19, Issue 9, 2023

Published on: 21 March, 2023

Article ID: e200223213799 Pages: 3

DOI: 10.2174/1573399819666230220120415

[1]
International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: IDF 2021.
[2]
Kuroda N, Kusunoki Y, Osugi K, et al. Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo diabetes hypoglycemia cognition complications study. J Diabetes Investig 2021; 12(2): 244-53.
[http://dx.doi.org/10.1111/jdi.13336] [PMID: 32594655]
[3]
American Diabetes Association Professional Practice Committee. 6. Glycemic targets: Standards of medical care in diabetes-2022. Diabetes Care 2022; 45: S83-96.
[http://dx.doi.org/10.2337/dc22-S006] [PMID: 34964868]
[4]
American Diabetes Association Professional Practice Committee. 7. Diabetes technology: Standards of medical care in diabetes-2022. Diabetes Care 2022; 45: S97-S112.
[http://dx.doi.org/10.2337/dc22-S007] [PMID: 34964871]
[5]
Monnier L, Colette C, Owens D. Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”? Diabetes Metab 2021; 47(3)101225
[http://dx.doi.org/10.1016/j.diabet.2021.101225] [PMID: 33454438]
[6]
American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of medical care in diabetes-2022. Diabetes Care 2022; 45: S144-74.
[http://dx.doi.org/10.2337/dc22-S010] [PMID: 34964815]
[7]
Sezer H, Yazici D, Copur S, Dagel T, Deyneli O, Kanbay M. The relationship between glycemic variability and blood pressure variability in normoglycemic normotensive individuals. Blood Press Monit 2021; 26(2): 102-7.
[http://dx.doi.org/10.1097/MBP.0000000000000491] [PMID: 33074929]
[8]
Alfieri V, Myasoedova VA, Vinci MC, et al. The role of glycemic variability in cardiovascular disorders. Int J Mol Sci 2021; 22(16): 8393.
[http://dx.doi.org/10.3390/ijms22168393] [PMID: 34445099]
[9]
Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: Systematic review and meta-analysis. BMJ 2016; 354: i4098.
[http://dx.doi.org/10.1136/bmj.i4098] [PMID: 27511067]
[10]
Chiriacò M, Pateras K, Virdis A, et al. Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obes Metab 2019; 21(12): 2587-98.
[http://dx.doi.org/10.1111/dom.13828] [PMID: 31282073]
[11]
Yapanis M, James S, Craig ME, O’Neal D, Ekinci EI. Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring. J Clin Endocrinol Metab 2022; 107(6): e2221-36.
[http://dx.doi.org/10.1210/clinem/dgac034] [PMID: 35094087]
[12]
Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of glycemic indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res 2020 2020.
[13]
Okumura K, Cheng XW. Blood pressure variability and vascular dysfunction in essential hypertension. J Korean Soc Hypertens 2012; 18(3): 75.
[http://dx.doi.org/10.5646/jksh.2012.18.3.75]
[14]
Raval J, Trivedi R, Suman S, Kukrety A, Prajapati P. Nano-biotechnology and its innovative perspective in diabetes management. Mini Rev Med Chem 2022; 22(1): 89-114.
[http://dx.doi.org/10.2174/1389557521666210623164052] [PMID: 34165408]

Rights & Permissions Print Cite
Article Metrics
21
2
© 2024 Bentham Science Publishers | Privacy Policy